Sponsored Links / Ads


Recent Leukemia/Lymphoma News
For high-risk leukemia patients, umbilical cord blood transplant associated with lower risk of relapse

Sept. 7, 2016 Umbilical cord blood transplants may have advantages beyond offering an alternative stem cell source for leukemia patients without a traditional donor match, according to a study ... [via Fred Hutchinson Cancer Research Center]

leukemia drug cuts death risk vs chemo in new patients: study

Johnson & Johnson's and AbbVie's cancer drug Imbruvica significantly reduced the risk of death and disease progression compared with chemotherapy in previously untreated patients with a type of ... [via Reuters]

Novartis trial shows drug improves survival for AML patients

ZURICH Novartis' phase III study for its acute myeloid leukemia drug showed it improved overall survival by 23 percent for patients with FLT3 mutations, the Swiss drugmaker said on Sunday.... [via Reuters]

Measuring treatment response proves to be a powerful tool for guiding leukemia treatment

St. Jude Childrens Research Hospital investigators report that measuring leukemia cells that persist in patient bone marrow in the early weeks of treatment helps identify high-risk patients who need ... [via St. Jude]

Scientists trace genomic evolution of high-risk leukemia

Highly sensitive genomic analysis of acute lymphoblastic leukemia cells reveals for the first time how the malignant cells evolve to cause relapse.... [via St. Jude]

Leukemia patients with gene variant may have increased risk of complications

Researchers have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used anti-cancer drug.... [via St. Jude]

Mother of bone marrow transplantation Dorothy Dottie Thomas dies

Jan. 10, 2015 Dorothy "Dottie" Thomas, thewife and research partner of1990 Nobel laureate E. Donnall Thomas, M.D., died the evening of Friday, Jan. 9. She was 92.... [via Fred Hutchinson Cancer Research Center]

Good news for young patients with a leukemia subtype associated with a poor prognosis

St. Jude Childrens Research Hospital study shows that adjusting treatment based on early response to chemotherapy boosts survival of young patients with Philadelphia chromosome-like acute ... [via St. Jude]

Studies Reveal Potential New Targeted Therapies for Common, Hard-to-Treat Cancers | ASCO.org

CHICAGO Positive results from four clinical trials of investigational targeted drugs for advanced ovarian, lung, and thyroid cancers, and chronic lymphocytic leukemia were highlighted today at the ... [via ASCO]

Prominent UCLA Stem Cell Researcher Inducted into Cancer Research Academy

STORY HIGHLIGHTS Scientist Dr. Owen Witte, UCLA Jonsson Comprehensive Cancer Center member and director of UCLAs Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research is a 2014 ... [via UCLA]

With health, not being perfect is OK

I am 52 years old. I was not overweight for the first 32 years of my life. Then the emotional stress of losing my daughter to leukemia caused me to gain 70 pounds.... [via CNN]

Chronically ill facing high drugs costs under U.S. health law

President Barack Obama's ban on discriminatory health insurance practices against the sick has not stopped insurers from increasing up-front charges for the expensive drugs needed to control chronic ... [via Reuters]

Experimental Treatment Eradicates Acute Leukemia in Mice

A diverse team of scientists from UCLAs Jonsson Comprehensive Cancer Center have developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic ... [via UCLA]

Caregivers: Supporting the supporters

Cancer has been a painful part of Radka Lakosilova's life. From four cycles of chemotherapy and a stem cell transplant, to losing weight, hair and friends, she's felt every moment.... [via CNN]

3-year-old is focus of medical marijuana battle

He's only 3 years old, but Landon Riddle is already the focus of a medical marijuana fight in Colorado. Landon has acute lymphocytic leukemia, or ALL, a cancer of the blood and bone marrow.... [via CNN]

Featured Leukemia/Lymphoma Articles

Lymphoma - Leukemia Bookstore 
 Books related to lymphoma treatment, survival and support. This site contains content for both patients and professionals.... [more]

Chronic Lymphocytic Leukemia Research - Results of DNA study offers clues for future treatments 
  SAN DIEGO—The most comprehensive search to date of DNA abnormalities in chronic lymphocytic leukemia (CLL) has unearthed several new altered genes that drive this common blood cancer, a finding that ... [more]

Stem Cell Transplantation and Radiolabeled Antibodies Used to Successfully Treat Advanced Leukemia 
  SEATTLE – For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell ... [more]

Complications of Autologous Stem Cell Transplantation 
 Autologous stem cell transplantation (ASCT) is now commonly used to treat a variety of illnesses including multiple myeloma, Hodgkin’s lymphoma, and non-Hodgkin’s lymphoma (see “Stem Cell Transplant” ... [more]

Lymphoma Research: New drug strategy attacks resistant leukemia and lymphoma 
  In proof-of-concept studies in mice with transplanted, drug-resistant leukemia tumors, the compound alone suppressed cancer growth, and when paired with other drugs, showed synergistic anti-cancer ... [more]

Gene Mutations Reveal Potential New Targets for Treating a Type of Non-Hodgkin's Lymphoma 
 Researchers have discovered genetic mutations that may contribute to the development of an aggressive form of non-Hodgkin's lymphoma. These findings provide insight into a mechanism that cancer cells ... [more]

Lymphoma Treatment: Study indicates that radioimmunotherapy effective over long term 
 Ann Arbor, MI- Eight years after being treated with a new drug for non-Hodgkin's lymphoma, 86 percent of patients were still alive and half had not had a relapse of their disease, according to ... [more]

High Dose Chemotherapy Significantly Prolongs Survival for Patients with Acute Myeloid Leukemia 
 Preliminary results from a large, randomized clinical trial for patients ages 16 to 60 with previously untreated acute myeloid leukemia (AML), a cancer of the blood and bone marrow, show that patients... [more]

Studying Mutations in Non-Hodgkin Lymphoma Yields Clues for Potential New Therapies 
  March 6, 2008: DNA mutations found in a type of non-Hodgkin lymphoma that has a poor prognosis has led researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, ... [more]

Chronic Lymphocytic Leukemia (CLL) Treatment Shows Benefit in Phase III Clinical Trial 
 The first "antisense" drug to be tested in chronic lymphocytic leukemia (CLL) shows benefit in a phase III clinical trial for a specific subset of patients... [more]

Acute Myelogenous Leukemia (AML) Patients May Benefit from New Class of Drug 
 Because of its harmful risk and side effects, chemotherapy may not be an option for older adults suffering from acute myelogenous leukemia (AML).... [more]

Researchers Find Abnormal Cells in the Blood Years before Leukemia is Diagnosed 
 Researchers have shown that abnormal white blood cells can be present in patients' blood more than six years prior to the diagnosis of a chronic form of lymphocytic leukemia. This finding may lead to ... [more]


These review articles are the opinions of the authors. Some of the views may be controversial. CancerNews.com™ does not directly endorse the work. We merely present it as part of our service. Please read the disclaimer.

This site is property of Net Ventures, Inc.